BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 34767753)

  • 21. Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.
    Zhao H; He Z; Li Y; Sun B
    BMC Microbiol; 2022 Nov; 22(1):262. PubMed ID: 36319965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and clinical outcomes of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria.
    Qureshi ZA; Syed A; Clarke LG; Doi Y; Shields RK
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3100-4. PubMed ID: 24637691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of carbapenem-resistant
    Zhou Y; Zhao Z; Zeng L; Peng J; Zhou S; Min L; Ke J; Liu J
    J Med Microbiol; 2022 Jan; 71(1):. PubMed ID: 35060850
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
    Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F;
    J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries.
    Hu Y; Yang Y; Feng Y; Fang Q; Wang C; Zhao F; McNally A; Zong Z
    PLoS Med; 2023 Jun; 20(6):e1004233. PubMed ID: 37339120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
    Huang W; Qiao F; Deng Y; Zhu S; Li J; Zong Z; Zhang W
    Eur J Clin Microbiol Infect Dis; 2023 May; 42(5):529-541. PubMed ID: 36856898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.
    Hauck C; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Scalera NM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
    Clin Microbiol Infect; 2016 Jun; 22(6):513-9. PubMed ID: 26850824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal spread of carbapenem-resistant Klebsiella pneumoniae among patients at admission and discharge at a Vietnamese neonatal intensive care unit.
    Berglund B; Hoang NTB; Lundberg L; Le NK; Tärnberg M; Nilsson M; Bornefall E; Khu DTK; Welander J; Le HT; Olson L; Dien TM; Nilsson LE; Larsson M; Hanberger H
    Antimicrob Resist Infect Control; 2021 Nov; 10(1):162. PubMed ID: 34801068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
    Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H
    J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
    Reyes J; Komarow L; Chen L; Ge L; Hanson BM; Cober E; Herc E; Alenazi T; Kaye KS; Garcia-Diaz J; Li L; Kanj SS; Liu Z; Oñate JM; Salata RA; Marimuthu K; Gao H; Zong Z; Valderrama-Beltrán SL; Yu Y; Tambyah P; Weston G; Salcedo S; Abbo LM; Xie Q; Ordoñez K; Wang M; Stryjewski ME; Munita JM; Paterson DL; Evans S; Hill C; Baum K; Bonomo RA; Kreiswirth BN; Villegas MV; Patel R; Arias CA; Chambers HF; Fowler VG; Doi Y; van Duin D; Satlin MJ;
    Lancet Microbe; 2023 Mar; 4(3):e159-e170. PubMed ID: 36774938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Molecular Epidemiology of Prevalent Klebsiella pneumoniae Strains and Humoral Antibody Responses against Carbapenem-Resistant K. pneumoniae Infections among Pediatric Patients in Shanghai.
    Wang J; Ma R; Pan F; Wu Y; Pan Y; Liu Y; Yu F; Yu J; Lun H; Shi Y; Zhang H; He P
    mSphere; 2022 Oct; 7(5):e0027122. PubMed ID: 36069436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.
    van Duin D; Arias CA; Komarow L; Chen L; Hanson BM; Weston G; Cober E; Garner OB; Jacob JT; Satlin MJ; Fries BC; Garcia-Diaz J; Doi Y; Dhar S; Kaye KS; Earley M; Hujer AM; Hujer KM; Domitrovic TN; Shropshire WC; Dinh A; Manca C; Luterbach CL; Wang M; Paterson DL; Banerjee R; Patel R; Evans S; Hill C; Arias R; Chambers HF; Fowler VG; Kreiswirth BN; Bonomo RA;
    Lancet Infect Dis; 2020 Jun; 20(6):731-741. PubMed ID: 32151332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors, Molecular Epidemiology, and Outcomes of Carbapenem-Resistant
    Zuo Y; Zhao D; Song G; Li J; Xu Y; Wang Z
    Microb Drug Resist; 2021 Feb; 27(2):204-211. PubMed ID: 32614722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics.
    Su S; Zhang J; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Li C; Zhang X
    BMC Infect Dis; 2020 Jul; 20(1):472. PubMed ID: 32616018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant
    Hu Y; Liu C; Shen Z; Zhou H; Cao J; Chen S; Lv H; Zhou M; Wang Q; Sun L; Sun Q; Hu F; Wang Y; Zhang R
    Emerg Microbes Infect; 2020 Dec; 9(1):1771-1779. PubMed ID: 32689907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
    Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
    Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.
    Giacobbe DR; Del Bono V; Bruzzi P; Corcione S; Giannella M; Marchese A; Magnasco L; Maraolo AE; Pagani N; Saffioti C; Ambretti S; Cardellino CS; Coppo E; De Rosa FG; Viale P; Viscoli C;
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):663-669. PubMed ID: 27909821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.